JP2007502101A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502101A5 JP2007502101A5 JP2006521226A JP2006521226A JP2007502101A5 JP 2007502101 A5 JP2007502101 A5 JP 2007502101A5 JP 2006521226 A JP2006521226 A JP 2006521226A JP 2006521226 A JP2006521226 A JP 2006521226A JP 2007502101 A5 JP2007502101 A5 JP 2007502101A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- acid sequence
- amino acid
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48984003P | 2003-07-24 | 2003-07-24 | |
| US52011503P | 2003-11-14 | 2003-11-14 | |
| PCT/US2004/023523 WO2005009379A2 (en) | 2003-07-24 | 2004-07-22 | Polypeptides for inducing a protective immune response against staphylococcus aureus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007502101A JP2007502101A (ja) | 2007-02-08 |
| JP2007502101A5 true JP2007502101A5 (https=) | 2007-05-24 |
Family
ID=34107815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006521226A Pending JP2007502101A (ja) | 2003-07-24 | 2004-07-22 | スタフィロコッカス・アウレウスに対して防御免疫応答を誘導するポリペプチド |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20060177462A1 (https=) |
| EP (1) | EP1651166B8 (https=) |
| JP (1) | JP2007502101A (https=) |
| KR (1) | KR20060065643A (https=) |
| AT (1) | ATE457737T1 (https=) |
| AU (1) | AU2004258979B2 (https=) |
| BR (1) | BRPI0412799A (https=) |
| CA (1) | CA2532370A1 (https=) |
| CY (1) | CY1110028T1 (https=) |
| DE (1) | DE602004025579D1 (https=) |
| DK (1) | DK1651166T3 (https=) |
| ES (1) | ES2342778T3 (https=) |
| HR (1) | HRP20100240T1 (https=) |
| IL (1) | IL173253A0 (https=) |
| IS (1) | IS8213A (https=) |
| MX (1) | MXPA06000854A (https=) |
| NO (1) | NO20060898L (https=) |
| NZ (2) | NZ570750A (https=) |
| PL (1) | PL1651166T3 (https=) |
| PT (1) | PT1651166E (https=) |
| RU (1) | RU2337108C2 (https=) |
| SI (1) | SI1651166T1 (https=) |
| WO (1) | WO2005009379A2 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| AU2005214061B2 (en) * | 2004-02-18 | 2010-02-04 | Merck Sharp & Dohme Corp. | Polypeptides for inducing a protective immune response against Staphylococcus aureus |
| EP1812066A4 (en) * | 2004-10-25 | 2010-06-30 | Univ Western Ontario | STAINLOCOCCUS AUREUS-BASED ANTI-INFECTION AGENTS ON ISD PROTEIN |
| GB0526038D0 (en) * | 2005-12-21 | 2006-02-01 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| CN101375161A (zh) * | 2006-01-27 | 2009-02-25 | 默克公司 | 靶定金黄色葡萄球菌ORF0657n的抗原结合蛋白 |
| EP2117574A4 (en) | 2007-01-24 | 2010-06-16 | Merck Sharp & Dohme | POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS EPIDERMIDIS |
| ATE537839T1 (de) * | 2007-05-04 | 2012-01-15 | Martin Kroenke | Impfstoff zum schutz gegen staphylococcus aureus auf der basis zellwandassoziierter proteine |
| BRPI0811193A2 (pt) * | 2007-05-31 | 2014-11-11 | Merck & Co Inc | Proteína de ligação a antígeno isolada, ácido nucleico, célula recombinante, métodos para produzir uma proteína e para proteger ou tratar contra uma infecção por s. aureus em paciente, composição farmacêutica, uso da proteína de ligação a antígeno, e, polipeptídeo. |
| EP2185195A2 (en) | 2007-08-16 | 2010-05-19 | Tripep Ab | Immunogen platform |
| US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
| EP2185190B1 (en) | 2007-08-31 | 2015-06-24 | University Of Chicago | Methods and compositions related to immunizing against staphylococcal lung diseases and conditions |
| WO2010014304A1 (en) | 2008-07-29 | 2010-02-04 | University Of Chicago | Compositions and methods related to staphylococcal bacterium proteins |
| AU2009319947A1 (en) | 2008-11-26 | 2010-06-03 | Merck Sharp & Dohme Corp. | Polypeptides for inducing a protective immune response against Staphylococcus aureus |
| ES2784957T3 (es) | 2009-04-03 | 2020-10-02 | Univ Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SPA) |
| MX2011010735A (es) | 2009-04-14 | 2012-01-25 | Novartis Ag | Composiciones para inmunizacion contra staphylococcus aureus. |
| GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| US8974799B2 (en) | 2009-09-30 | 2015-03-10 | Novartis Ag | Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides |
| BR112012010223A2 (pt) | 2009-10-30 | 2016-12-06 | Novartis Ag | purificação de staphylococcus aureus tipo 5 e tipo 8 sacarídeos capsulares |
| GB0919690D0 (en) | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
| US20130004539A1 (en) * | 2010-03-12 | 2013-01-03 | Jeffrey Weiser | Methods for preventing and treating staphylococcus aureus colonization, infection, and disease |
| JP6002128B2 (ja) | 2010-07-02 | 2016-10-05 | ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ | プロテインＡ（ＳｐＡ）変種に関連する組成物および方法 |
| EP2593133A4 (en) | 2010-07-13 | 2014-11-26 | Merck Sharp & Dohme | STAPHYLOCOCCUS AUREUS SURFACE PROTEIN SA1789 AND PROTECTIVE VACCINE BASED ON IT |
| EP2638058B1 (en) | 2010-11-12 | 2017-01-11 | Merck Sharp & Dohme Corp. | Enolase peptide conjugate vaccines against staphylococcus aureus |
| US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| SG11201400210RA (en) | 2011-09-01 | 2014-03-28 | Novartis Ag | Adjuvanted formulations of staphylococcus aureus antigens |
| EP2773370A4 (en) | 2011-10-31 | 2016-09-28 | Merck Sharp & Dohme | PROTECTIVE VACCINE BASED ON THE STAPHYLOCOCCUS AUREUS PROTEIN SA2451 |
| MX354862B (es) * | 2012-06-27 | 2018-03-23 | Hoffmann La Roche | Método para la producción de entidades dirigidas altamente selectivas hechas a la medida y biespecíficas que contienen dos entidades de unión diferentes. |
| WO2014001325A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof |
| WO2014011645A1 (en) | 2012-07-10 | 2014-01-16 | Merck Sharp & Dohme Corp. | Protective vaccine based on staphylococcus aureus sa2493 protein |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| MX2021013833A (es) | 2019-05-14 | 2022-03-17 | Univ Chicago | Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa). |
| WO2021051136A1 (en) | 2019-09-13 | 2021-03-18 | The University Of Chicago | Methods and compositions for treating staphylococcal infections |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| JP2003503015A (ja) * | 1999-05-03 | 2003-01-28 | メダレツクス・インコーポレーテツド | スタフィロコッカス・アウレウスに対するヒト抗体 |
| GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
| AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| JP4424984B2 (ja) * | 2001-06-15 | 2010-03-03 | インヒビテックス インコーポレーテッド | コアグラーゼ陰性ブドウ球菌および黄色ブドウ球菌由来の表面蛋白質を認識する、交差反応性モノクローナルおよびポリクローナル抗体 |
| ATE421977T1 (de) * | 2001-11-12 | 2009-02-15 | Novo Nordisk As | Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie |
| JP2005532415A (ja) * | 2001-12-11 | 2005-10-27 | メルク エンド カムパニー インコーポレーテッド | スタフィロコッカス・アウレウスエキソポリサッカライド及び方法 |
| US20080050361A1 (en) * | 2004-10-25 | 2008-02-28 | Heinrichs David E | Staphylococcus aureas specific anti-infectives |
| US20090317421A1 (en) * | 2006-01-18 | 2009-12-24 | Dominique Missiakas | Compositions and methods related to staphylococcal bacterium proteins |
-
2004
- 2004-07-22 AT AT04778847T patent/ATE457737T1/de active
- 2004-07-22 KR KR1020067001610A patent/KR20060065643A/ko not_active Ceased
- 2004-07-22 NZ NZ570750A patent/NZ570750A/en not_active IP Right Cessation
- 2004-07-22 NZ NZ544542A patent/NZ544542A/en not_active IP Right Cessation
- 2004-07-22 US US10/564,458 patent/US20060177462A1/en not_active Abandoned
- 2004-07-22 JP JP2006521226A patent/JP2007502101A/ja active Pending
- 2004-07-22 RU RU2006105498/13A patent/RU2337108C2/ru not_active IP Right Cessation
- 2004-07-22 BR BRPI0412799-4A patent/BRPI0412799A/pt not_active Application Discontinuation
- 2004-07-22 WO PCT/US2004/023523 patent/WO2005009379A2/en not_active Ceased
- 2004-07-22 HR HR20100240T patent/HRP20100240T1/hr unknown
- 2004-07-22 MX MXPA06000854A patent/MXPA06000854A/es active IP Right Grant
- 2004-07-22 DE DE602004025579T patent/DE602004025579D1/de not_active Expired - Lifetime
- 2004-07-22 EP EP04778847A patent/EP1651166B8/en not_active Expired - Lifetime
- 2004-07-22 CA CA002532370A patent/CA2532370A1/en not_active Abandoned
- 2004-07-22 PT PT04778847T patent/PT1651166E/pt unknown
- 2004-07-22 AU AU2004258979A patent/AU2004258979B2/en not_active Ceased
- 2004-07-22 DK DK04778847.6T patent/DK1651166T3/da active
- 2004-07-22 PL PL04778847T patent/PL1651166T3/pl unknown
- 2004-07-22 SI SI200431389T patent/SI1651166T1/sl unknown
- 2004-07-22 ES ES04778847T patent/ES2342778T3/es not_active Expired - Lifetime
-
2005
- 2005-12-30 IS IS8213A patent/IS8213A/is unknown
-
2006
- 2006-01-19 IL IL173253A patent/IL173253A0/en unknown
- 2006-02-23 NO NO20060898A patent/NO20060898L/no not_active Application Discontinuation
-
2010
- 2010-04-30 US US12/771,345 patent/US20100247561A1/en not_active Abandoned
- 2010-05-14 CY CY20101100419T patent/CY1110028T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007502101A5 (https=) | ||
| RU2006105498A (ru) | Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus | |
| CN114634556B (zh) | 一种新冠病毒Delta和Omicron变异株嵌合抗原、其制备方法和应用 | |
| Lecordier et al. | Characterization of a dense granule antigen of Toxoplasma gondii (GRA6) associated to the network of the parasitophorous vacuole | |
| JP2008529558A5 (https=) | ||
| JP2002510494A5 (https=) | ||
| JP2006516189A5 (https=) | ||
| JPH09322781A5 (https=) | ||
| JP2002542827A5 (https=) | ||
| JP2008538183A5 (https=) | ||
| JP2002531129A5 (https=) | ||
| CN116041448B (zh) | 新型冠状病毒免疫原性物质、其制备方法和应用 | |
| CA2385325A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| RU2011122615A (ru) | Живой аттенуированный респираторно-синцитиальный вирус | |
| CN117050193B (zh) | 一种β冠状病毒重组嵌合抗原、其制备方法及应用 | |
| WO1993020844A1 (en) | Papillomavirus e7 protein | |
| WO2024067725A1 (zh) | 一种融合前构象的呼吸道合胞病毒重组融合蛋白、其制备方法及用途 | |
| JP2002511847A (ja) | Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓに関連した歯周病の診断および治療のための合成ペプチド構築物 | |
| JP2004502446A5 (https=) | ||
| JPH0775546B2 (ja) | 水痘−帯状疱疹ウイルスにたいするワクチン | |
| JP2005512518A5 (https=) | ||
| JP2004532037A5 (https=) | ||
| TW200716166A (en) | Lawsonia intracellularis immunological proteins | |
| US20230220012A1 (en) | High-potency sars coronavirus 2 antigen and vaccine composition comprising same | |
| Kitada et al. | Multi-gene family of major surface glycoproteins of Pneumocystis carinii: full-size cDNA cloning and expression |